PRKCD and chronic obstructive pulmonary disease: Our results show that YPL-001 and its iridoids suppress the TNF/NF-κB/MUC5AC and PMA/PKCδ/EGR-1 cascades, which are important signaling pathways involved in inflammatory lung diseases, including COPD and asthma.